Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virotech Diagnostics, now operating as Sekisui Virotech GmbH, is a specialized biotechnology company based in Rüsselsheim, Germany, that focuses on the development and production of in vitro diagnostic (IVD) kits. Founded in 1986, the company has established itself as a leader in serological testing for infectious diseases, particularly known for its comprehensive portfolio of ELISA and line assays. Their product range covers a wide spectrum of pathogens, including those responsible for Lyme borreliosis, respiratory infections, and various viral diseases. In 2013, the company was acquired by Sekisui Chemical, integrating it into the Sekisui Diagnostics global network. Virotech serves clinical laboratories and hospitals worldwide, providing reliable tools for the detection of antibodies and antigens. The company continues to innovate in the field of immunology and microbiology to improve diagnostic accuracy and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virotech.